Intelligent Bio Solutions (INBS) Receivables (2021 - 2024)
Intelligent Bio Solutions has reported Receivables over the past 4 years, most recently at $764117.0 for Q1 2024.
- Quarterly results put Receivables at $764117.0 for Q1 2024, down 12.62% from a year ago — trailing twelve months through Mar 2024 was $764117.0 (down 12.62% YoY), and the annual figure for FY2023 was $792619.0, down 62.71%.
- Receivables for Q1 2024 was $764117.0 at Intelligent Bio Solutions, up from $552001.0 in the prior quarter.
- Over the last five years, Receivables for INBS hit a ceiling of $2.9 million in Q1 2022 and a floor of $341499.0 in Q4 2022.
- Median Receivables over the past 4 years was $874505.0 (2023), compared with a mean of $1.4 million.
- Biggest five-year swings in Receivables: plummeted 87.93% in 2022 and later skyrocketed 61.64% in 2023.
- Intelligent Bio Solutions' Receivables stood at $2.8 million in 2021, then tumbled by 87.93% to $341499.0 in 2022, then skyrocketed by 61.64% to $552001.0 in 2023, then soared by 38.43% to $764117.0 in 2024.
- The last three reported values for Receivables were $764117.0 (Q1 2024), $552001.0 (Q4 2023), and $1.1 million (Q3 2023) per Business Quant data.